These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 3881978)

  • 1. Acute and chronic actions of bradykinin on renal function and arterial pressure.
    Granger JP; Hall JE
    Am J Physiol; 1985 Jan; 248(1 Pt 2):F87-92. PubMed ID: 3881978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin.
    Lortie M; Regoli D; Rhaleb NE; Plante GE
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R72-6. PubMed ID: 1310238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that intrarenal bradykinin plays a role in regulation of renal function.
    Siragy HM
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E648-54. PubMed ID: 8238340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among endotoxemia, arterial pressure, and renal function in dogs.
    O'Hair DP; Adams MB; Tunberg TC; Osborn JL
    Circ Shock; 1989 Mar; 27(3):199-210. PubMed ID: 2650915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
    Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; Pelà GM; Novarini A; Cabassi A; Montanari A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intrarenal angiotensin II infusion on the renal escape from mineralocorticoid.
    Opgenorth TJ; Granger JP; Chakravarthy A; Knox FG; Romero JC
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F813-8. PubMed ID: 4073265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal infusion of bradykinin elicits a pressor response in conscious rats via a B2-receptor mechanism.
    Hoagland KM; Maddox DA; Martin DS
    Can J Physiol Pharmacol; 1999 Aug; 77(8):563-70. PubMed ID: 10543719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal haemodynamic and excretory responses to bradykinin in anaesthetized dogs.
    Matsumura Y; Tadano K; Yamasaki T
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):645-50. PubMed ID: 10474781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bradykinin on renal function in dogs treated with indomethacin or propranolol.
    Yun JC; Gill JR; Bartter FC; Kelly GD; Keiser HR
    Ren Physiol; 1982; 5(1):31-43. PubMed ID: 7079557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bradykinin and papaverine on renal autoregulation and renin release in the anaesthetized dog.
    Bugge JF; Stokke ES; Kiil F
    Acta Physiol Scand; 1991 Dec; 143(4):431-7. PubMed ID: 1815477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics in response to a kinin analogue antagonist.
    Beierwaltes WH; Carretero OA; Scicli AG
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F408-14. PubMed ID: 3414801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs.
    Hall JE; Granger JP
    Am J Physiol; 1986 Jan; 250(1 Pt 2):F32-9. PubMed ID: 3942225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs.
    Cowley AW; Lohmeier TE
    Hypertension; 1979; 1(6):549-58. PubMed ID: 396248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic and vasodilating activities of intrarenally administered atriopeptin II, substance P and bradykinin in the dog.
    DeFelice AF; Brousseau A
    J Pharmacol Exp Ther; 1988 Jul; 246(1):183-8. PubMed ID: 2455790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs.
    Katholi RE; Carey RM; Ayers CR; Vaughan ED; Yancey MR; Morton CL
    Circ Res; 1977 May; 40(5 Suppl 1):I118-26. PubMed ID: 870220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intrarenal NO stimulates renin secretion through a macula densa-mediated mechanism.
    Schnackenberg CG; Tabor BL; Strong MH; Granger JP
    Am J Physiol; 1997 Mar; 272(3 Pt 2):R879-86. PubMed ID: 9087651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
    Levens N; Beil M; Jarvis M
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sensitivity to angiotensin II in the conscious dog.
    Siragy HM; Lamb NE; Woodson JF; Ragsdale NV; Rose CE; Peach MJ; Carey RM
    Endocrinology; 1987 Apr; 120(4):1272-8. PubMed ID: 3549257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.